75 related articles for article (PubMed ID: 3045770)
1. [Results of the treatment of non-lymphoblastic leukemia with small doses of cytosine arabinoside].
Brodzki LM; Pawelski S; Gepner-Woźniewska M
Pol Tyg Lek; 1988 Mar; 43(11):355-8. PubMed ID: 3045770
[No Abstract] [Full Text] [Related]
2. [Preliminary results of the treatment of various forms of non-lymphoblastic leukemia with small doses of cytosine arabinoside].
Brodzki LM; Pawelski S; Gepner-Woźniewska M
Pol Tyg Lek; 1986 Oct; 41(43):1376-9. PubMed ID: 3469629
[No Abstract] [Full Text] [Related]
3. [Intensive post-remission therapy of acute myeloid leukemia with high doses of cytosine arabinoside].
Slechtová J; Koza V; Svojgrová M; Cepelák V
Cas Lek Cesk; 1989 Sep; 128(39):1239-42. PubMed ID: 2582468
[TBL] [Abstract][Full Text] [Related]
4. Low dose cytosine arabinoside in the treatment of acute non-lymphoblastic leukemia.
Insiripong S; Thaisamakr S
J Med Assoc Thai; 1996 Sep; 79(9):568-71. PubMed ID: 8996985
[TBL] [Abstract][Full Text] [Related]
5. Low dose cytosine arabinoside in adult acute non-lymphoid leukemia.
Rossi Ferrini P; Ciolli S; Leoni F
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():36-7. PubMed ID: 2713558
[No Abstract] [Full Text] [Related]
6. [Therapy of patients with myeloid leukemia with small doses of cytosine arabinoside].
Patterson D; Kravtsova VM; Petrova EM; Zabelina TS; Balaian LN
Ter Arkh; 1987; 59(12):81-6. PubMed ID: 3482131
[TBL] [Abstract][Full Text] [Related]
7. [Results of treating acute myeloid leukemia resistant to conventional chemotherapy with moderately large doses of cytarabine and etoposide].
Robak T; Krykowski E; Matusewicz W; Brodowski L; Hołub A; Drzewoski J
Pol Tyg Lek; 1988 Nov; 43(47):1508-11. PubMed ID: 3075284
[No Abstract] [Full Text] [Related]
8. [Preliminary results of the treatment of non-lymphoblastic leukemia and bone marrow dysplasia with small doses of cytosine arabinoside].
Brodzki LM
Acta Haematol Pol; 1985; 16(1-2):85-9. PubMed ID: 3914171
[No Abstract] [Full Text] [Related]
9. [Comparative evaluation of a combination of daunorubicin and cytosine arabinoside and that of aclarubicin and cytosine arabinoside in remission induction in acute non-lymphocytic leukemia].
Takahashi I; Hara M; Ohmoto E; Oda Y; Endo Y; Fujimoto S; Uchida K; Takaoka K; Watanabe S; Lai M; Kohi F; Kitajima K; Kimura I; Sanada H; Tokioka M; Adachi T; Yorimitsu S
Gan To Kagaku Ryoho; 1982 Sep; 9(9):1617-22. PubMed ID: 6964050
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of acute myeloid leukemia in adults with a combination of daunomycin and cytosine-arabinoside].
Brincker H
Ugeskr Laeger; 1972 Oct; 134(42):2195-200. PubMed ID: 4563112
[No Abstract] [Full Text] [Related]
11. [Results of cytosine arabinoside treatment in adult patients with acute myeloblastic leukemia].
Gepner-Woźniewska M; Retmańska A; Sobczynska-Czechowska Z; Pawelski S
Acta Haematol Pol; 1973; 4(1):1-9. PubMed ID: 4522083
[No Abstract] [Full Text] [Related]
12. [Reduced dosage of cytosine arabinoside in the treatment of acute myelocytic leukemia. Apropos of 3 cases].
Andrey C; Beris P; Plancherel C; de Loes S; Maurice P; Chapuis B
Schweiz Med Wochenschr; 1983 Jul; 113(27-28):980-4. PubMed ID: 6577584
[TBL] [Abstract][Full Text] [Related]
13. [Low-dose cytosine arabinoside (ARA-C) in the treatment of acute myeloid leukemia].
Beris P; Rieder A; Andrey C; Helg C; Chapuis B
Schweiz Med Wochenschr; 1984 Dec; 114(48):1763-6. PubMed ID: 6596706
[TBL] [Abstract][Full Text] [Related]
14. [Treatment of acute myeloblastic leukemia with daunorubicin and cytosine-arabinoside].
Thorling K; Petersen HS; Jensen KB; Bastrup-Madsen P
Ugeskr Laeger; 1972 Oct; 134(42):2201-5. PubMed ID: 4507751
[No Abstract] [Full Text] [Related]
15. [Comparison of the effects of cytosine arabinoside, cytosine arabinoside and thioguanine, and cytosine arabinoside and daunorubicin in acute myeloid leukemia].
Malpas J; Mathé G; Hayat M
Bull Cancer; 1974; 61(3):411-8. PubMed ID: 4533741
[No Abstract] [Full Text] [Related]
16. Mitoxantrone and cytosine arabinoside (ARA-C) in adult acute leukemia: an interim report.
Kansu E; Koc Y; Kars A; Alakavuklar M; Tekuzman G; Firat D
J Chemother; 1989 Jul; 1(4 Suppl):1268-70. PubMed ID: 16312861
[No Abstract] [Full Text] [Related]
17. High dose cytosine arabinoside in the treatment of adult acute myelogenous leukaemia.
Nemet D; Labar B; Bogdanić V; Hauptman E; Jaksić B; Minigo H; Sertić D; Mrsić M; Pavletić Z; Kovacević J
Bone Marrow Transplant; 1989 Dec; 4 Suppl 3():42-4. PubMed ID: 2697399
[No Abstract] [Full Text] [Related]
18. [Low-dose cytosine arabinoside treatment in acute myeloid leukemia].
Jensen MK; Ahlbom G; Leegaard OF
Ugeskr Laeger; 1984 Aug; 146(35):2613-5. PubMed ID: 6595867
[No Abstract] [Full Text] [Related]
19. [Treatment of acute myeloid leukemia in the elderly with low-dose cytosine arabinoside].
Pedersen G; Stentoft J; Pedersen JO; Jensen MK
Ugeskr Laeger; 1994 Oct; 156(43):6380-4. PubMed ID: 7810014
[TBL] [Abstract][Full Text] [Related]
20. [Sequential combination of high-dose cytosine arabinoside and L-asparaginase in the treatment of refractory acute leukemia and malignant lymphoma].
Shimazaki C; Fujita N; Nakanishi S; Nishio A; Haruyama H; Nakagawa M; Ijichi H
Gan To Kagaku Ryoho; 1985 Nov; 12(11):2202-7. PubMed ID: 3864396
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
